$NTLA 3 SEC Filings

Filed On	Filing
23 Jan 2025	Form 3: Schultes Birgit C, EVP, Chief Scientific Officer Holds 67,615 shares of Common Stock
24 Jul 2024	Form 3: Dulac Edward J Iii, EVP, Chief Financial Officer No securities owned
17 Jun 2024	Form 3: Goff Brian, Director No securities owned
22 Apr 2024	Form 3: Dube Michael P, Principal Accounting Officer Holds 31,223 shares of Common Stock
18 Apr 2023	Form 3: Chase William J, Director Holds 6,800 shares of Common Stock
02 May 2022	Form 3: Bhanji Muna, Director No securities owned
07 Mar 2022	Form 3: Clark Eliana, EVP, Chief Technical Officer Holds 5,638 shares of Common Stock
29 Dec 2021	Form 3: Hicks Derek, EVP, Chief Business Officer No securities owned
06 Jul 2021	Form 3: Basta James, EVP, General Counsel No securities owned
13 Apr 2021	Form 3: Keresty Georgia, Director No securities owned
05 Oct 2020	Form 3: Crowley John F, Director No securities owned
05 May 2020	Form 3: Lebwohl David, EVP, Chief Medical Officer No securities owned
29 May 2019	Form 3: Sepp-Lorenzino Laura, EVP, Chief Scientific Officer No securities owned
24 Jan 2019	Form 3: Cohen Fred E, Director No securities owned
31 Oct 2018	Form 3: Goodman Jesse, Director No securities owned
29 Oct 2018	Form 3: Goddard Glenn, See Remarks No securities owned
10 Aug 2018	Form 3: Hayes John T., See Remarks
27 Apr 2018	Form 3: Schiermeier Andrew, See Remarks
23 Mar 2018	Form 3: Novartis Institutes for BioMedical Research, Inc., 10% owner and 1 other Holds 4,277,073 shares of Common Stock
25 Jul 2017	Form 3: Verwiel Frank, Director No securities owned

Comments